ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia
Science Advances · 2024
DOI: 10.1126/sciadv.adj8803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Kira Behrens und 10 weiteren Autor:innen. Beteiligte Einrichtung: Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. Hauptthemen laut MEDLINE: Fusion Proteins, bcr-abl, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Transcriptional Regulator ERG. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Philadelphia chromosome–positive B cell acute lymphoblastic leukemia (B-ALL), characterized by the BCR::ABL1 fusion gene, remains a poor prognosis cancer needing new therapeutic approaches. Transcriptomic profiling identified up-regulation of oncogenic transcription factors ERG and c-MYC in BCR::ABL1 B-ALL with ERG and c-MYC required for BCR::ABL1 B-ALL in murine and human models. Profiling of ERG- and c-MYC–dependent gene expression and analysis of ChIP-seq data established ERG and c-MYC coordinate a regulatory network in BCR::ABL1 B-ALL that controls expression of genes involved in several biological processes. Prominent was control of ribosome biogenesis, including expression of RNA polymerase I (POL I) subunits, the importance of which was validated by inhibition of BCR::ABL1 cells by POL I inhibitors, including CX-5461, that prevents promoter recruitment and transcription initiation by POL I. Our results reveal an essential ERG- and c-MYC–dependent transcriptional network involved in regulation of metabolic and ribosome biogenesis pathways in BCR::ABL1 B-ALL, from which previously unidentified vulnerabilities and therapeutic targets may emerge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
- Department of Medical Biology, University of Melbourne, Parkville, Australia.
- Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
- Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
- Department of Clinical Pathology, University of Melbourne, Parkville, Australia.
ORCID-Profile: Kira Behrens, Natalie Brajanovski, Ladina DiRago, Soroor Hediyeh-Zadeh, Elaine Sanij, Ashley P Ng
Zitieren
APA
Behrens, K., Brajanovski, N., Xu, Z., Viney, E. M., DiRago, L., Hediyeh-Zadeh, S., Davis, M. J., Pearson, R. B., Sanij, E., Alexander, W. S., & Ng, A. P. (2024). ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia. Science Advances. https://doi.org/10.1126/sciadv.adj8803
Vancouver
Behrens K, Brajanovski N, Xu Z, Viney EM, DiRago L, Hediyeh-Zadeh S, et al. ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia. Science Advances. 2024. doi:10.1126/sciadv.adj8803
BibTeX
@article{Behrens2024,
author = {Behrens, Kira and Brajanovski, Natalie and Xu, Zhen and Viney, Elizabeth M and DiRago, Ladina and Hediyeh-Zadeh, Soroor and Davis, Melissa J and Pearson, Richard B and Sanij, Elaine and Alexander, Warren S and Ng, Ashley P},
title = {ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adj8803}
}
EUVIMED